Evidence Library
Filter by drug, type, year, and open access.
Showing 1–4 of 4 results
- Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: systematic review and network meta-analysis — The Lancet (2022)• Drug: zaleplonDOIPMID
- FDA boxed warning for serious injuries caused by complex sleep behaviors with certain prescription insomnia medicines — FDA Drug Safety Communication (2019)• Drug: zaleplonOpen access
- Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline — Journal of Clinical Sleep Medicine (2017)• Drug: zaleplonOpen accessDOIPMIDPMCID
- Zaleplon improves sleep without producing rebound effects in outpatients with insomnia — International Clinical Psychopharmacology (2000)• Drug: zaleplonDOIPMID